The Woodcock Effect: Is The New CDER Director Approving More Drugs?
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysts, CEOs speculate whether Janet Woodcock's leadership has resulted in a better climate for drug approvals at FDA.